Erschienen in:
01.05.2016 | Pediatric Rheumatology (S Ozen, Section Editor)
Pediatric Mixed Connective Tissue Disease
verfasst von:
Roberta A. Berard, Ronald M. Laxer
Erschienen in:
Current Rheumatology Reports
|
Ausgabe 5/2016
Einloggen, um Zugang zu erhalten
Abstract
Pediatric-onset mixed connective tissue disease is among the rare disease entities in pediatric rheumatology and includes features of arthritis, polymyositis/dermatomyositis, systemic lupus erythematosus, and systemic sclerosis. Accurate recognition and diagnosis of the disease is paramount to prevent long-term morbidity. Advances in the genetic and immunologic understanding of the factors involved in the etiopathogenesis provide an opportunity for improvements in prognostication and targeted therapy. The development of a multinational cohort of patients with mixed connective tissue disease would be invaluable to provide more updated data regarding the clinical presentation, to develop a standardized treatment approach, disease activity and outcome tools, and to provide data on long-term outcomes and comorbidities.